**Biotech rNPV / probability-of-success engine for AI agents.** Audit-grade asset valuation with signed dossier exports, cell-level evidence registers, and asset-anchored competitive landscape — the same engine healthcare investors and tech transfer offices use to value early-stage biotech assets, e
View & run on Rokha →